SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tracking a lifelong treatment for debilitating fever diseases
Disease control Recruiting nowThis study is observing how safe and effective the drug Ilaris is for people already taking it to manage rare hereditary fever conditions and a type of juvenile arthritis. It will follow both children and adults for up to four years in real-world clinical settings. The goal is to…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
Gentler transplant offers hope for kids with rare, Life-Limiting diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy regimen before a stem cell transplant for children and young adults with inherited disorders like sickle cell disease, immune deficiencies, and metabolic diseases. The goal is to see if this gentler approach helps donor stem cells…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC